Spectral Medical Inc. (TSE:EDT - Get Free Report) shares passed above its 50 day moving average during trading on Friday . The stock has a 50 day moving average of C$0.74 and traded as high as C$0.83. Spectral Medical shares last traded at C$0.83, with a volume of 43,896 shares trading hands.
Spectral Medical Stock Up 2.5 %
The company has a market capitalization of C$233.44 million, a price-to-earnings ratio of -11.86 and a beta of 0.96. The firm's 50 day moving average price is C$0.74 and its two-hundred day moving average price is C$0.62. The company has a current ratio of 0.61, a quick ratio of 0.45 and a debt-to-equity ratio of 26.03.
Spectral Medical Company Profile
(
Get Free Report)
Spectral Medical Inc is focused on the development and commercialization of a treatment for septic shock utilizing its endotoxin activity assay (EAA) diagnostic and the toraymyxin therapeutic. The company also manufactures and sells proprietary reagents. The product line of the company consists of proprietary biochemical, EAA, and instrumentation.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Spectral Medical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Spectral Medical wasn't on the list.
While Spectral Medical currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
